{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:11:36Z","timestamp":1767211896087,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jid.2018.08.021","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T14:29:32Z","timestamp":1538144972000},"page":"439-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts"],"prefix":"10.1016","volume":"139","author":[{"given":"Saliha","family":"Harrach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Barz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Pap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Pavenst\u00e4dt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Schlatter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayram","family":"Edemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Distler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliano","family":"Ciarimboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.08.021_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2018.08.021_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.semarthrit.2012.06.001","article-title":"Therapeutic inhibition of tyrosine kinases in systemic sclerosis: a review of published experience on the first 108 patients treated with imatinib","volume":"42","author":"Bournia","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jid.2018.08.021_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/BOR.0b013e3283454124","article-title":"New therapies in the management of rheumatoid arthritis","volume":"23","author":"Buch","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jid.2018.08.021_bib4","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/art.30284","article-title":"The c-Abl tyrosine kinase controls protein kinase Cdelta-induced Fli-1 phosphorylation in human dermal fibroblasts","volume":"63","author":"Bujor","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2018.08.021_bib5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41467-017-01236-6","article-title":"Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2018.08.021_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.21725","article-title":"Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts","volume":"54","author":"Chen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2018.08.021_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0738-081X(95)00076-R","article-title":"Measurement of skin pH and its significance in cutaneous diseases","volume":"13","author":"Chikakane","year":"1995","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jid.2018.08.021_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2006.07.004","article-title":"Systemic and localized scleroderma","volume":"24","author":"Chung","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jid.2018.08.021_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/17425255.2011.547474","article-title":"Role of organic cation transporters in drug-induced toxicity","volume":"7","author":"Ciarimboli","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jid.2018.08.021_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrrheum.2009.82","article-title":"Tyrosine kinases as targets for the treatment of rheumatoid arthritis","volume":"5","author":"D\u2019Aura Swanson","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2018.08.021_bib11","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/ard.2010.134742","article-title":"Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis","volume":"70","author":"Dees","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2018.08.021_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.22314","article-title":"Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis","volume":"56","author":"Distler","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2018.08.021_bib13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/path.1427","article-title":"The myofibroblast in wound healing and fibrocontractive diseases","volume":"200","author":"Gabbiani","year":"2003","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jid.2018.08.021_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1523-1747.ep12276895","article-title":"Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma","volume":"92","author":"Gay","year":"1989","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.08.021_bib15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/blood-2012-01-405035","article-title":"The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia","volume":"121","author":"Giannoudis","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.08.021_bib16","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1073\/pnas.0408624102","article-title":"Discovery of the ergothioneine transporter","volume":"102","author":"Grundemann","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2018.08.021_bib17","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1038\/bcj.2016.79","article-title":"MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients","volume":"6","author":"Harrach","year":"2016","journal-title":"Blood Cancer J"},{"issue":"Suppl. 7","key":"10.1016\/j.jid.2018.08.021_bib18","first-page":"S157","article-title":"The role of transporters in the toxicity of chemotherapeutic drugs: focus on transporters for organic cations","volume":"56","author":"Hucke","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jid.2018.08.021_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/jpet.109.163642","article-title":"Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine","volume":"333","author":"Ito","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jid.2018.08.021_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jid.2018.08.021_bib21","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.1780331011","article-title":"Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis","volume":"33","author":"Klareskog","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2018.08.021_bib22","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2018.08.021_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jid.2018.08.021_bib24","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2018.08.021_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1741-7015-12-43","article-title":"What is the future of targeted therapy in rheumatology: biologics or small molecules?","volume":"12","author":"Mocsai","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jid.2018.08.021_bib26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1078-0432.CCR-13-1999","article-title":"Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1)","volume":"20","author":"Nies","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2018.08.021_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jdermsci.2007.05.017","article-title":"Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases","volume":"49","author":"Okuyama","year":"2008","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2018.08.021_bib28","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1073\/pnas.0506483102","article-title":"A\u00a0human transporter protein that mediates the final excretion step for toxic organic cations","volume":"102","author":"Otsuka","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2018.08.021_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ncprheum0465","article-title":"Imatinib for the treatment of rheumatic diseases","volume":"3","author":"Paniagua","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jid.2018.08.021_bib30","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1101\/gad.13.18.2400","article-title":"c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF","volume":"13","author":"Plattner","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2018.08.021_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1172\/JCI116235","article-title":"Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis","volume":"91","author":"Sano","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2018.08.021_bib32","series-title":"Role of transporters for organic cations in plants for environmental cycline of\u00a0pharmaceutical resdiues","first-page":"139","article-title":"Physiological and pathophysiological regulation of transporters for organic cations","author":"Schlatter","year":"2016"},{"issue":"12","key":"10.1016\/j.jid.2018.08.021_bib33","doi-asserted-by":"crossref","first-page":"e52247","DOI":"10.1371\/journal.pone.0052247","article-title":"Transport mechanisms and their pathology-induced regulation govern tyrosine kinase inhibitor delivery in rheumatoid arthritis","volume":"7","author":"Schmidt-Lauber","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2018.08.021_bib34","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/art.27382","article-title":"Selective expression of connective tissue growth factor in fibroblasts in\u00a0vivo promotes systemic tissue fibrosis","volume":"62","author":"Sonnylal","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2018.08.021_bib35","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood-2013-11-535864","article-title":"Does the haplotype Met408-Del420, which was apparently predictive for imatinib efficacy, really exist and how strongly may it affect OCT1 activity?","volume":"123","author":"Tzvetkov","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.08.021_bib36","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2009.26.5819","article-title":"Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with imatinib","volume":"28","author":"White","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2018.08.021_bib37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1182\/blood-2005-11-4687","article-title":"OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in\u00a0vitro sensitivity to imatinib","volume":"108","author":"White","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jid.2018.08.021_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jchromb.2004.01.006","article-title":"Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection","volume":"803","author":"Widmer","year":"2004","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jid.2018.08.021_bib39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2018.08.021_bib40","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2018.08.021_bib41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1124\/mol.51.6.913","article-title":"Cloning and functional expression of a human liver organic cation transporter","volume":"51","author":"Zhang","year":"1997","journal-title":"Mol Pharmacol"},{"issue":"Suppl. 3","key":"10.1016\/j.jid.2018.08.021_bib42","first-page":"iii23","article-title":"Immunological basis of systemic sclerosis","volume":"45","author":"Zuber","year":"2006","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18326423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18326423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:12:28Z","timestamp":1758301948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18326423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0022202X18326423"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.08.021","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}